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Preliminary and Short Report
THIABENDAZOLE INHIBITION OF VENOM NECROSIS*
ORVILLE J. STONE, M.D., CAROLYN J. WILLIS, M.A.
AND J. FRED MULLINS, M.D.
Thiabendazole is both an anthelmintic (1) and
an antifungal (2) agent. In the dermatologic dis-
ease processes we have studied, "creeping erup-
tion" (3, 4) and superficial fungus infections (5),
the organisms have depended on protcolytic activ-
ity to remain in or on the epidermis. Although we
have shown the ability of the drug to kill various
stages of hookworm larvae (6), we have noted
that the disease proccssGs would resolve if the
drug inhibited their protcolytic activity (6). The
rapid symptomatic improvement of trichinosis
in spite of continued presence of some larvae
(7, 8) could be explained by inhibition of pro-
teolytic activity. However, there are many other
factors that need to be considered, such as the
fact that adult trichinella in the intestine arc
not eliminated and can produce more larvae, and
the fact that the symptoms of trichinosis depend
on the quantity of larvae present. There is no
doubt that thiabcndazolc kills trichinella larvae
in certain dosages and at certain stages (9).
The mode of action of thiabendazole is, to our
knowledge, unknown. The drug is known to be a
chelating agent (10) and, therefore, may act by
binding metals of proteolytic enzymes or by bind-
ing essential substances.
The purpose of this report is to evaluate the
effect of thiabcndazolc on the protcolytic activity
of the venom of the cottonmouth moccasin(Agkistrodon piscivorus). Thiabendazolc is well
distributed through body tissue when given orally
and seems safe for intravenous or intralesional
therapy, and perhaps for arterial perfusion. There is
a need for substances that inhibit the proteolytic
activity of enzymes of insects, spiders, mites, and
snakes.
MzTllOD
Ten adult white male guinea pigs were each in-jected intradcrmally at four sites on the back
with A) .05 ml. of equal parts of thiabendazole
(400 meg/mI) mixed with venom of Aqkistrodon
piscivorus (600 mcg/ml) incubated together at
room temperature for one hour. Sterile distilled
water was used for the dilution of venom and
thiabendazole. B) .05 ml of venom (300 meg/mI),
C) .05 ml of venom (600 mcg/ml) followed by an
injection of thiabcndazole .15 ml (200 mcg/ml)
into the same site. D) .05 ml of venom (600 meg!
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ml) followed by an injection of .15 ml of distilled
water.
The lesions were read for size of area of hemor-
rhage and necrosis at 24 and 48 hours. The read-
ings arc similar enough that only the 48 hour
changes will be reported.
RE5ULT5
Site A. There was no hemorrhage or necrosis at
the injection site. There was 2 mm of crythcma in
2 animals.
Site B. Average hemorrhage was 7.25 mm.
(range 5—8 mm) Average necrosis was 3.5 mm.
(range 1—5 mm)
Site C. Average hemorrhage 623 mm. (range
3—9 mm.) Average necrosis 1.2 mm. (range 0-3
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mm)
Site D. Average hemorrhage 10.33 mm (range 9-.
11 mm.). Average necrosis 7 mm. (range 4—9 mm.).
Comparison of Site A and Site B shows that the
mixing of the venom and thiabcndazolc in vitro
completely inhibited hemorrhage (average 7.25
mm.) and necrosis (average 3.5 mm) that oc-
curred at the control site.
Comparison of Site C and Site D showed that by
injecting thiabendazolc into the site of venom in-
jection, the hemorrhage was reduced from a 10.33
mm average to a 6.33 mm average, and the
necrosis was reduced from a 7 mm. average to a
12 mm average.
DIsCUssION
Venoms arc extremely complex substances and
contain materials other than protcolytic enzymes
so that it is difficult to fully understand the role
of chelating agents in inhibiting their activity.
Flowers and Couchcr (11, 12) have reviewed the
background data on ethylcncdiaminctctriacetic
acid (EDTA) and its effect on vcnoms. Working
with the vcnoms of Bothrops atrox (fcr-de-
lance) and Agkistrodon piscivorus (cottonmouth
moccasin), they showed that EDTA decreases
hemorrhage and necrosis if injected immediately
following cnvcnomation,
We have shown that thiabendazolc will inhibit
the tissue damaging effect of cottonmouth moc-
casin venom if the substances arc mixed in vitro.
If the thiabcndazolc is injected immediately after
intradcrmal envenomation, tissue damage is de-
creased.
Thiabcndazole appears to be a very safe sub-
stance which rapidly penetrates tissue. It would
lend itself well to further investigations on en-
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venomation. It also differs from EDTA in that it
does not bind calcium, nor produce renal damage.
Since calcium is required for most immunologic
reactions, chelating agents which hind calcium
might interfere with simultaneous antivenom
therapy.
Inhibition of proteolytic enzymes by chelating
agents may lead to methods of therapy for para-
sites or fungi which require proteolytic activity
if they are to maintain their position in the
epidermis.
Albert and co-workers (13) have shown that 8-
hydroxyquinoline exerts its antifungal and anti-
bacterial action through a metal chelate. Shulman
and Dwyer (14) feel that on the basis of present
experimental evidence, it is often difficult to de-
cide if chelating ability is merely an incidental
chemical property of many drugs. They also dis-
cuss some promising clinical topical therapeutic
uses for metal chelates against superficial infec-
tious processes.
SUMMARY
1. Thiabendazole (200 mcg/ml) completely in-
hibited the tissue damaging activity of cotton-
mouth moccasin venom (300 mcg/ml) when in-
cubated together for one hour at room
temperature and injected intradermally into the
guinea pig.
2. Thiabendazole (0.15 ml of 200 mcg/ml) in-jected immediately after the venom decreased
tissue damage from cottonmouth moccasin venom
(0.05 ml of 600 mcg/ml).
3. Thiabendazole or other chelating agents may
he of future value in decreasing tissue damage
from venoms containing proteolytic enzymes.
4. The inhibition of proteolytic activity as
demonstrated in the designs of this paper do not
necessarily prove that this is the drug's mechanism
of anthelmintic or antifungal activity. It is known
that thiabendazole has a lethal effect on certain
nematodes and fungi.
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